GILEAD SCIENCES, INC. for GILEAD SCIENCES INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 21, 2008 | $250,000 | Replaced |
| 2nd Quarter - Amendment | Oct 28, 2008 | $260,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Programs for the developing world; International trade and health policy issues [e.g. TRIPS (Trade Related Aspects of Intellectual Property Rights) and programs for the developing world]; Public health programs for HIV and Hepatitis; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTIN LIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.